No Detail Found!

Rationality of antibiotic use in COVID-19 patients in the ICU of Dr. Hasan Sadikin General Hospital, Bandung; a cohort study

Author(s)
Indriasari Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Padjadjaran University, Hospital Dr. Hasan Sadikin, Bandung, Indonesia
Ezra Oktaliansah Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Padjadjaran University, Hospital Dr. Hasan Sadikin, Bandung, Indonesia
Rikda Irham Munazat Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Padjadjaran University, Hospital Dr. Hasan Sadikin, Bandung, Indonesia
Abstract
Background and Objectives: Nearly three-quarters of the patients with COVID-19 received antibiotic therapy despite the bacterial coinfection being only less than 10% in many studies and ranging from 8-22% in ICU patients. The use of broad-spectrum antibiotics in COVID-19 patients has not been proven effective. Overuse of antibiotics may be associated with side effects and antibiotic resistance. The purpose of this study was to determine the antibiotic rationality in COVID-19 patients in the ICU of Dr. Hasan Sadikin Hospital, Bandung, Indonesia. Methodology: This descriptive, retrospective cohort study was carried out by analyzing medical records of COVID-19 patients admitted in the ICU of Dr. Hasan Sadikin Hospital from January-June 2021. Results: There were 138 patients who met the inclusion criteria. A total of 126 (91.3%) patients received antibiotics. A total of 12 (8.7%) severe/critical patients did not receive antibiotics and 79 (62.70%) received inappropriate antibiotic duration. Inappropriate regimen was found in 59 patients (74.68%) with COVID-19 without HAP/VAP and 15 patients (31.92%) with HAP/VAP. The primary issue identified was the inappropriate regimen of antibiotics, Gyssens category 4a. Conclusion: This study concludes that 23.02% patients used rational empirical antibiotics and 45.98% used rational definitive antibiotics in COVID-19 patients in the ICU at RSUP Dr. Hasan Sadikin Bandung during January-June 2021. 
Publication Details
Page(s) 115-125
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 28, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
antibiotics, Antimicrobial resistance, COVID-19, COVID-19, Intensive Care Units, Covid-19, prescribing pattern
References
Hajjar LA,Costa IBS da S,Rizk SI,Biselli B,Gomes BR,Bittar CS .2021 .Intensive care management of patients with COVID19: a practical approach. , 11(1) : 36.
. .. , : .
Petteys MM,Medaris LA,Williamson JE,Soman RS,Denmeade TA,Anderson WE . .Outcomes and antibiotic use in patients with coronavirus disease 2019 (COVID-19) admitted to an intensive care unit. Antimicrob Steward Healthc Epidemiol., : .
.2021 .. , 2(1) : e12.
Langford BJ,So M,Raybardhan S,Leung V,Soucy JR,Westwood D . .Antibiotic prescribing in patients with COVID19: rapid review and meta-analysis. Clin Microbiol Infect., : .
.2020 .. , 12(4) : 520-31.
Pedoman Tatalaksana .2022 .. , : .
.2019 .. , 200(7) : 1581ST-67.
Sutrisno E. .2013 .Impact of irrational antibiotic therapy to hospital cost of care of pneumonia in patients in Dr. Sardjito Hospital. Acta Interna J Intern Med, 3(2) : 67-71.
. .Antibiotic use and associated risk factors for antibiotic prescribing in COVID-19 hospitalized patients. J Pharm Pract., : .
.2023 .. , 36(2) : 256-63.
Kamara IF,Kumar AM V,Maruta A,Fofanah BD,Njuguna CK . .. , 9 : .
Shongwe S .2022 .Antibiotic use in suspected and confirmed COVID-19 patients admitted to health facilities in Sierra Leone in 2020-2021: Practice does not follow policy. Int J Environ Res Public Health, 19(7) : 4005.
Dietl B,Boix-Palop L,Gisbert L,Mateu A,Garreta G,Xercavins M .2023 .Risk factors associated with inappropriate empirical antimicrobial treatment in bloodstream infections. A cohort study. Front Pharmacol, 14 : 1132530.
Haessler S,Lindenauer PK,Zilberberg MD,Imrey PB,Yu PC,Higgins T .2020 .Blood cultures versus respiratory cultures: 2 different views of pneumonia. Clin Infect Dis, 71(7) : 1604-12.
Cut TG,Mavrea A,Cumpanas AA,Novacescu D,Oancea CI,Bratosin F .2023 .A Retrospective Assessment of Sputum Samples and Antimicrobial Resistance in COVID-19 Patients. , 12(4) : 620.
Luciana T,Andrajati R,Rianti A,Khan AH .2015 .Rational antimicrobial use in an Intensive Care Unit in Jakarta, Indonesia: A hospitalbased, cross-sectional study. Trop J Pharm Res, 10(4) : 21-14.
Molla MMA,Yeasmin M,Islam MK,Sharif MM,Amin MR,Nafisa T .2021 .Antibiotic prescribing patterns at COVID-19 dedicated wards in Bangladesh: Findings from a single center study. Infect Prev Pract, 3(2) : 100134.
Tan SH,Ng TM,Tay HL,Yap MY,Heng ST,Loo AYX .2020 .A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19). J Glob Antimicrob Resist, 11 : 45-7.
Malik SS,Mundra S. .2022 .Increasing consumption of antibiotics during the COVID-19 pandemic: Implications for patient health and emerging anti-microbial resistance. Antibiotics, 12(1) : 45.
Garcia-Vidal C,Sanjuan G,Moreno-García E,Puerta-Alcalde P,Garcia-Pouton N,Chumbita M .2020 .Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect, 07(1) : 83-8.
Calderón-Parra J,Muiño-Miguez A,Bendala-Estrada AD,Ramos-Martínez A,Muñez-Rubio E,Fernández Carracedo E .2021 .Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One, 16(5) : e0251340.
Di Gennaro F,Marotta C,Amicone M,Bavaro DF,Bernaudo F,Frisicale EM .2020 .Italian young doctors' knowledge, attitudes and practices on antibiotic use and resistance: A national crosssectional survey. J Glob Antimicrob Resist, 08 : 167-73.
0

Citations

0

Downloads

59

Views